Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001641172-25-015693
Filing Date
2025-06-20
Accepted
2025-06-20 06:15:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 10951
  Complete submission text file 0001641172-25-015693.txt   12763
Mailing Address 212 MAPLE AVENUE RED BANK NJ 07701
Business Address 212 MAPLE AVENUE RED BANK NJ 07701 646-306-2210
Gravitas Capital LP (Filed by) CIK: 0001840140 (see all company filings)

EIN.: 320298616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D

Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Subject) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-94246 | Film No.: 251058983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)